Literature DB >> 22297139

Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe.

J Mereckiene1, S Cotter, J T Weber, A Nicoll, F D'Ancona, P L Lopalco, K Johansen, A M Wasley, P Jorgensen, D Lévy-Bruhl, C Giambi, P Stefanoff, L Dematte, D O'Flanagan.   

Abstract

In August 2010 the Vaccine European New Integrated Collaboration Effort (VENICE) project conducted a survey to collect information on influenza A(H1N1)pdm09 vaccination policies and vaccination coverage in the European Union (EU), Norway and Iceland. Of 29 responding countries, 26 organised national pandemic influenza vaccination and one country had recommendations for vaccination but did not have a specific programme. Of the 27 countries with vaccine recommendations, all recommended it for healthcare workers and pregnant women. Twelve countries recommended vaccine for all ages. Six and three countries had recommendations for specific age groups in children and in adults, countries for specific adult age groups. Most countries recommended vaccine for those in new risk groups identified early in the pandemic such as morbid obese and people with neurologic diseases. Two thirds of countries started their vaccination campaigns within a four week period after week 40/2009. The reported vaccination coverage varied between countries from 0.4% to 59% for the entire population (22 countries); 3% to 68% for healthcare workers (13 countries); 0% to 58% for pregnant women (12 countries); 0.2% to 74% for children (12 countries). Most countries identified similar target groups for pandemic vaccine, but substantial variability in vaccination coverage was seen. The recommendations were in accordance with policy advice from the EU Health Security Committee and the World Health Organization.

Entities:  

Mesh:

Year:  2012        PMID: 22297139     DOI: 10.2807/ese.17.04.20064-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  30 in total

1.  Developing pandemic preparedness in Europe in the 21st century: experience, evolution and next steps.

Authors:  Angus Nicoll; Caroline Brown; Franz Karcher; Pasi Penttinen; Michala Hegermann-Lindencrone; Silvia Villanueva; Massimo Ciotti; Lucie Jean-Gilles; Sybille Rehmet; Jonathan S Nguyen-Van-Tam
Journal:  Bull World Health Organ       Date:  2012-04-01       Impact factor: 9.408

2.  Meeting report narcolepsy and pandemic influenza vaccination: What we know and what we need to know before the next pandemic? A report from the 2nd IABS meeting.

Authors:  Kathryn Edwards; Germaine Hanquet; Steve Black; Emmanuel Mignot; Christopher Jankosky; Tom Shimabukuro; Elizabeth Miller; Hanna Nohynek; Pieter Neels
Journal:  Biologicals       Date:  2019-05-23       Impact factor: 1.856

3.  Influenza in obese travellers: increased risk and complications, decreased vaccine effectiveness.

Authors:  Rebekah Honce; Stacey Schultz-Cherry
Journal:  J Travel Med       Date:  2019-05-10       Impact factor: 8.490

4.  Trust and the demand for autonomy may explain the low rates of immunizations among nurses.

Authors:  Orna Baron-Epel; Batya Madjar; Rami Grefat; Shmuel Rishpon
Journal:  Hum Vaccin Immunother       Date:  2012-10-29       Impact factor: 3.452

5.  Impact of vitamin D administration on immunogenicity of trivalent inactivated influenza vaccine in previously unvaccinated children.

Authors:  Nicola Principi; Paola Marchisio; Leonardo Terranova; Alberto Zampiero; Elena Baggi; Cristina Daleno; Silvia Tirelli; Claudio Pelucchi; Susanna Esposito
Journal:  Hum Vaccin Immunother       Date:  2013-01-16       Impact factor: 3.452

6.  Blood libel rebooted: traditional scapegoats, online media, and the H1N1 epidemic.

Authors:  L Atlani-Duault; A Mercier; C Rousseau; P Guyot; J P Moatti
Journal:  Cult Med Psychiatry       Date:  2015-03

7.  Evaluation of the potential effects of AS03-adjuvanted A(H1N1)pdm09 vaccine administration on the central nervous system of non-primed and A(H1N1)pdm09-primed cotton rats.

Authors:  Camille Planty; Corey P Mallett; Kevin Yim; Jorge C G Blanco; Marina Boukhvalova; Thomas March; Robbert van der Most; Eric Destexhe
Journal:  Hum Vaccin Immunother       Date:  2016-09-14       Impact factor: 3.452

8.  Respiratory tract infections during the 2011 Mycoplasma pneumoniae epidemic.

Authors:  N Reinton; L Manley; T Tjade; A Moghaddam
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-01-25       Impact factor: 3.267

9.  Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland.

Authors:  Markku Partinen; Outi Saarenpää-Heikkilä; Ismo Ilveskoski; Christer Hublin; Miika Linna; Päivi Olsén; Pekka Nokelainen; Reija Alén; Tiina Wallden; Merimaaria Espo; Harri Rusanen; Jan Olme; Heli Sätilä; Harri Arikka; Pekka Kaipainen; Ilkka Julkunen; Turkka Kirjavainen
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

Review 10.  Modeling rapidly disseminating infectious disease during mass gatherings.

Authors:  Gerardo Chowell; Hiroshi Nishiura; Cécile Viboud
Journal:  BMC Med       Date:  2012-12-07       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.